{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:15Z","timestamp":1792794255919,"version":"4.5.0"},"reference-count":32,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background:<\/jats:title>\n<jats:p>Psoriasis is associated with significant morbidity and impaired quality of life. Identification of the host genes that influence disease susceptibility and can potentially guide future, targeted therapy is the need of the hour.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Aims:<\/jats:title>\n<jats:p>The aim of the study was to investigate the associations of macrophage migration inhibitory factor (MIF) gene polymorphisms, that is, a 5\u20138-CATT tetra nucleotide repeats at -794 (-794*CATT<jats:sub>5\u20138<\/jats:sub>) and a single-nucleotide polymorphism at -173 (-173*G\/C) with the risk of chronic plaque psoriasis and to observe the correlation, if any, of disease determinants with genetic functional variants and circulating MIF levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Methods:<\/jats:title>\n<jats:p>Five hundred and seventeen individuals (265 psoriasis patients and 252 controls) were genotyped for MIF gene polymorphisms. Data were analyzed with respect to disease susceptibility, serum MIF levels, disease severity, age at onset, disease duration and presence of comorbidities.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>Results:<\/jats:title>\n<jats:p>The presence of co-morbidities was more frequently noted in patients with late onset disease (<jats:italic>P<\/jats:italic> = 0.01). No statistically significant differences were observed either in genotype (<jats:italic>P<\/jats:italic> = 0.680) or allele frequency (<jats:italic>P<\/jats:italic> = 0.69) with respect to distribution of MIF-173*G\/C polymorphism between patients and controls. The frequencies of genotypes -794*CATT 5\/7 and 7\/7 were significantly lower in patients (<jats:italic>P<\/jats:italic> = 0.027* and 0.038*, respectively). CATT*<jats:sub>5<\/jats:sub>\/MIF-173*C haplotype occurred at a higher frequency in patients (odds ratio 3.03, 95% confidence intervals 1.09\u20138.47, <jats:italic>P<\/jats:italic> = 0.02). The mean serum MIF levels were significantly higher in patients as compared to controls (<jats:italic>P<\/jats:italic> &lt; 0.001). The presence of either extended MIF -794*CATT repeats or C allele did not reveal any significant association with serum MIF levels or age at onset. Analysis of effect of various disease determinants revealed no significant association with genetic variants and serum MIF levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st5\">\n<jats:title>Limitations:<\/jats:title>\n<jats:p>The lesional expression of MIF could not be studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st6\">\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our results showed that CATT*<jats:sub>5<\/jats:sub>\/MIF-173*C haplotype is associated with increased susceptibility to psoriasis vulgaris.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijdvl_988_19","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T04:58:04Z","timestamp":1620622684000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Single-nucleotide polymorphism and haplotype analysis of macrophage migration inhibitory factor gene and its correlation with serum macrophage migration inhibitory factor levels in North Indian psoriatic patients with moderate disease severity: A cross-sectional study"],"prefix":"10.25259","volume":"89","author":[{"given":"Seema","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmalya","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Cytology and Gynaecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Bishnoi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frainey","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari","family":"Priyanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana Walker","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"key":"10.25259\/IJDVL_988_19\/ref-1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4103\/0378-6323.72443","article-title":"Psoriasis in India: Prevalence and patterns","volume":"76","author":"Dogra","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJDVL_988_19\/ref-2","first-page":"273","article-title":"Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SPP)","volume":"77","author":"Enerb\u00e4ck","year":"1997","journal-title":"Acta DermVenereol"},{"key":"10.25259\/IJDVL_988_19\/ref-3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/BF03401892","article-title":"Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland","volume":"1","author":"Nishino","year":"1995","journal-title":"Mol Med"},{"key":"10.25259\/IJDVL_988_19\/ref-4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.183.1.277","article-title":"An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction","volume":"183","author":"Bernhagen","year":"1996","journal-title":"J Exp Med"},{"key":"10.25259\/IJDVL_988_19\/ref-5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids","volume":"42","author":"Leech","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.25259\/IJDVL_988_19\/ref-6","doi-asserted-by":"publisher","first-page":"S513","DOI":"10.1086\/432009","article-title":"Macrophage migration inhibitory factor: Gene polymorphisms and susceptibility to inflammatory diseases","volume":"41","author":"Renner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.25259\/IJDVL_988_19\/ref-7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/geno.1996.4505","article-title":"Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2","volume":"39","author":"Budarf","year":"1997","journal-title":"Genomics"},{"key":"10.25259\/IJDVL_988_19\/ref-8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1006\/geno.1995.1070","article-title":"Genomic cloning of mouse MIF (macrophage inhibitory factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes","volume":"27","author":"Kozak","year":"1995","journal-title":"Genomics"},{"key":"10.25259\/IJDVL_988_19\/ref-9","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.25259\/IJDVL_988_19\/ref-10","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/art.10492","article-title":"Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis","volume":"46","author":"Donn","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.25259\/IJDVL_988_19\/ref-11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fimmu.2016.00098","article-title":"Impact of MIF gene promoter variations on risk of rheumatic heart disease and its age of onset in Saudi Arabian patients","volume":"7","author":"Abdallah","year":"2016","journal-title":"Front Immunol"},{"key":"10.25259\/IJDVL_988_19\/ref-12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1164\/rccm.200307-933OC","article-title":"Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy","volume":"169","author":"Hizawa","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.25259\/IJDVL_988_19\/ref-13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2156-5-2","article-title":"Complex genetic predisposition in adult and juvenile rheumatoid arthritis","volume":"5","author":"Miterski","year":"2004","journal-title":"BMC Genet"},{"key":"10.25259\/IJDVL_988_19\/ref-14","first-page":"1671","article-title":"Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"key":"10.25259\/IJDVL_988_19\/ref-15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.gene.6363867","article-title":"A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis","volume":"3","author":"Baugh","year":"2002","journal-title":"Genes Immun"},{"key":"10.25259\/IJDVL_988_19\/ref-16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/1475-2875-12-345","article-title":"Variations MIF gene polymorphisms in psoriasis in ncRNA gene LOC284889 and MIF-794CATT repeats are associated with malaria susceptibility in Indian populations","volume":"12","author":"Jha","year":"2013","journal-title":"Malar J"},{"key":"10.25259\/IJDVL_988_19\/ref-17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.0022-202X.2004.23314.x","article-title":"Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis","volume":"123","author":"Donn","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdermsci.2008.11.002","article-title":"Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China","volume":"53","author":"Wu","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.25259\/IJDVL_988_19\/ref-19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0190-9622(97)80394-5","article-title":"The genetics of psoriasis","volume":"37","author":"Henseler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bjd.13585","article-title":"New immune system genetic polymorphisms associated with moderate-to-severe plaque psoriasis: A case-control study","volume":"172","author":"Prieto-P\u00e9rez","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.molimm.2014.11.015","article-title":"Association analysis of GWAS and candidate gene loci in a Pakistani population with psoriasis","volume":"64","author":"Munir","year":"2015","journal-title":"Mol Immunol"},{"key":"10.25259\/IJDVL_988_19\/ref-22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/rheumatology\/ket363","article-title":"Age at disease onset: A key factor for understanding psoriatic disease","volume":"53","author":"Queiro","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.25259\/IJDVL_988_19\/ref-23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.0022-202X.2004.23511.x","article-title":"The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis","volume":"124","author":"Allen","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.jid.5700118","article-title":"Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-Cand HLA-B-typed patients","volume":"126","author":"Gudjonsson","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1440-0960.2011.00802.x","article-title":"Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population","volume":"53","author":"Armesto","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-26","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1007\/s10875-012-9781-1","article-title":"MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity","volume":"33","author":"Bucala","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.25259\/IJDVL_988_19\/ref-27","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.3748\/wjg.v19.i39.6656","article-title":"Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: An association study in New Zealand Caucasians and meta-analysis","volume":"19","author":"Falvey","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.25259\/IJDVL_988_19\/ref-28","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1002\/art.21285","article-title":"Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor","volume":"52","author":"Radstake","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.25259\/IJDVL_988_19\/ref-29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/gast.2002.34236","article-title":"Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice","volume":"123","author":"Ohkawara","year":"2002","journal-title":"Gastroenterology"},{"key":"10.25259\/IJDVL_988_19\/ref-30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1523-1747.ep12319304","article-title":"HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics","volume":"109","author":"Mallon","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-31","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1046\/j.1523-1747.1998.00213.x","article-title":"Genetics of psoriasis: Paternal inheritance and a locus on chromosome 6p","volume":"110","author":"Burden","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_988_19\/ref-32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","article-title":"High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis","volume":"116","author":"Shimizu","year":"2001","journal-title":"J Invest Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/single-nucleotide-polymorphism-and-haplotype-analysis-of-macrophage-migration-inhibitory-factor-gene-and-its-correlation-with-serum-macrophage-migration-inhibitory-factor-levels-in-north-indian-psoria\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/single-nucleotide-polymorphism-and-haplotype-analysis-of-macrophage-migration-inhibitory-factor-gene-and-its-correlation-with-serum-macrophage-migration-inhibitory-factor-levels-in-north-indian-psoria\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T11:29:12Z","timestamp":1679570952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/single-nucleotide-polymorphism-and-haplotype-analysis-of-macrophage-migration-inhibitory-factor-gene-and-its-correlation-with-serum-macrophage-migration-inhibitory-factor-levels-in-north-indian-psoria\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":32,"alternative-id":["10.25259\/IJDVL_988_19"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_988_19","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"article-number":"247"}}